roche holding ag-genusschein
(RHO5:Xetra)
Last €197.35 EUR
Change Today -1.77 / -0.89%
Volume 6.1K
As of 2:13 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).
Key Executives - roche holding ag-genusschein (RHO5)
| Name | Board Relationships | Title | Age |
| Severin Schwan | 31 Relationships | Chief Executive Officer and Director | 45 |
| Franz B. Humer | 132 Relationships | Chairman of the Board and Chairman of Presidium of the Board of Directors/Nomination Committee | 66 |
| Alan Hippe | 53 Relationships | Chief Financial and IT Officer | 45 |
| Ian T. Clark | 136 Relationships | Head of Global Product Strategy and Chief Executive Officer of Genentech | 51 |
| Hal V. Barron M.D., F.A.C.C. | 8 Relationships | Chief Medical Officer | 49 |
Board Members - roche holding ag-genusschein (RHO5)
| Name | Board Relationships | Primary Company | Age |
| Franz B. Humer | 132 Relationships | Roche Holding AG | 66 |
| Severin Schwan | 31 Relationships | Roche Holding AG | 45 |
| André Hoffmann | 61 Relationships | Givaudan SA | 54 |
| Fritz Gerber | 26 Relationships | Zurich Insurance Group AG | 83 |
| Andreas Oeri | 13 Relationships | Roche Holding AG | 63 |
Executive Committees* - roche holding ag-genusschein (RHO5)
| Committee Name | Chairperson | Board Relationships | Members |
| Audit Committee | Dame A. Deanne Shirley Julius CBE, Ph.D.(Econ) | 44 Relationships | 4 Executives |
| Compensation Committee | André Hoffmann | 61 Relationships | 4 Executives |
| Nominating Committee | Franz B. Humer | 132 Relationships | 2 Executives |
| Corporate Governance Committee | Andreas Oeri | 13 Relationships | 4 Executives |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| RHO5:GR | €197.35 EUR | -1.77 |  |
| Company | Last | Change |
| GlaxoSmithKline PLC | 1,713 GBp | +5.00 |
| Merck & Co Inc | $45.99 USD | -0.38 |
| Novartis AG | SFr.71.75 CHF | -0.45 |
| Pfizer Inc | $28.96 USD | -0.29 |
| Sanofi | €84.50 EUR | -0.12 |
| View Industry Companies | ||
Industry Analysis
RHO5
Industry Average
| Valuation | RHO5 | Industry Range |
| Price/Earnings | 20.9x |
|
| Price/Sales | 4.2x |
|
| Price/Book | 13.7x |
|
| Price/Cash Flow | 17.2x |
|
| TEV/Sales | 2.6x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
